Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03289507 · ClinicalTrials.gov registry record · NA

Longvida Curcumin Human Pharmacokinetics Study

A NA study of Healthy, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.

Completed
Registry status
NA
Development phase
9
Enrollment target
1
Study location

NCT03289507 is a NA study of Healthy that has completed, run by Clinical Nutrition Research Center, Illinois Institute of Technology. The registered enrollment target is 9 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03289507, a NA study of Healthy, has completed, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.

COMPLETED
Registry status
NA
Development phase
9 participants
Enrollment target
1
Study location

Study Summary

The primary objective of the study is to characterize the curcumin metabolites of 2 different capsule formulations of curcumin relative to unformulated Curcuma longa extract of Rhizomes including assessing relative bioavailability and absorption/kinetic profile of curcumonoids and their metabolites in human plasma and urine after acute consumption.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Treatment1
  • DIETARY_SUPPLEMENT Treatment2
  • DIETARY_SUPPLEMENT Treatment3

Study Locations (1)

Illinois

  • Clinical Nutrition Research Center - Chicago

Trial Details

FieldValue
Enrollment Target 9 participants
Start Date 2017-09-19
Est. Completion 2018-01-30
Phase NA

What the Registry Record Tells You About NCT03289507

The ClinicalTrials.gov registry entry for NCT03289507 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (99% lower). The listed sponsor is Clinical Nutrition Research Center, Illinois Institute of Technology, which has 59 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 3 interventions - of which Treatment1 is the first listed.

NCT03289507 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT03289507 about?

NCT03289507 is a clinical study titled "Longvida Curcumin Human Pharmacokinetics Study". The primary objective of the study is to characterize the curcumin metabolites of 2 different capsule formulations of curcumin relative to unformulated Curcuma longa extract of Rhizomes including assessing relative bioavailability and absorption/kinetic profile of curcumonoids and their metabolites ...

What is the current status of trial NCT03289507?

This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2017-09-19. Estimated completion is 2018-01-30.

What conditions does trial NCT03289507 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT03289507?

The interventions under investigation include: Treatment1 (DIETARY_SUPPLEMENT), Treatment2 (DIETARY_SUPPLEMENT), Treatment3 (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT03289507?

This trial is sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology, which has 59 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03289507 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.